Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Net Income (2024 - 2025)

Carlsmed (CARL) has disclosed Net Income for 2 consecutive years, with -$8.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Income fell 77.71% year-over-year to -$8.3 million, compared with a TTM value of -$16.9 million through Dec 2025, changed N/A, and an annual FY2025 reading of -$29.3 million, down 21.54% over the prior year.
  • Net Income was -$8.3 million for Q4 2025 at Carlsmed, up from -$9.4 million in the prior quarter.
  • Across five years, Net Income topped out at $5.5 million in Q2 2025 and bottomed at -$9.4 million in Q3 2025.